Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Ukraine is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine are shifting towards more natural and organic remedies. Consumers are becoming increasingly health-conscious and are seeking products that are perceived to be more natural and have fewer side effects. This has led to a growing demand for herbal and plant-based remedies in the market. Additionally, customers are also looking for products that are convenient and easy to use, such as tablets or capsules that can be taken on-the-go. Trends in the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine are being influenced by global and regional market trends. One of the key trends is the increasing prevalence of digestive and intestinal disorders, such as irritable bowel syndrome and acid reflux, which is driving the demand for remedies in the market. Additionally, there is a growing awareness and acceptance of alternative medicine practices, such as traditional Chinese medicine and Ayurveda, which offer holistic approaches to digestive health. This is leading to the introduction of new products in the market that cater to these alternative medicine practices. Local special circumstances in Ukraine are also contributing to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The country has a large aging population, which is more prone to digestive and intestinal disorders. This demographic trend is driving the demand for remedies in the market. Furthermore, Ukraine has a well-established pharmaceutical industry, which allows for the development and production of a wide range of digestive and intestinal remedies. This local expertise and infrastructure are supporting the growth of the market. Underlying macroeconomic factors are also playing a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine. The country has been experiencing economic growth in recent years, which has led to an increase in disposable income levels. This has allowed consumers to spend more on healthcare products, including digestive and intestinal remedies. Additionally, the government has been investing in healthcare infrastructure and promoting the use of generic medicines, which has made remedies more accessible and affordable for the population. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as consumers become more health-conscious and seek natural and convenient remedies for digestive and intestinal disorders.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
